| Literature DB >> 31372236 |
Melanie A Lloyd1,2, Clarice Y Tang1,3,4, Emily J Callander5, Edward D Janus2,6, Amalia Karahalios7, Elizabeth H Skinner1,8,9, Stephanie Lowe1, Harin A Karunajeewa2,6,10.
Abstract
BACKGROUND: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide, but few studies have evaluated the feasibility of routine patient-reported outcome measures (PROMs) in this illness. This study investigates the feasibility and limitations of three credible PROM instruments in a representative hospitalized cohort to identify potential barriers to routine application.Entities:
Keywords: Aged; Comorbidity; Inpatients; Multimorbidity; Outcome assessment; Pneumonia
Year: 2019 PMID: 31372236 PMCID: PMC6661077 DOI: 10.1186/s40814-019-0481-y
Source DB: PubMed Journal: Pilot Feasibility Stud ISSN: 2055-5784
Fig. 1Subject flow through the study. More than one reason for ineligibility may apply to a single participant; hence, the tally does not total 24. Abbreviations: CAP community-acquired pneumonia, NESB non-English speaking background, PROMs patient-reported outcome measures
Baseline characteristics, disease severity, and recovery of patients presenting with CAP: October–December 2016
| Consenting participants* | Declined participation or excluded* | ||
|---|---|---|---|
| ( | ( | ||
| Demographics | Age (years) | 73.5 [63.0–80.0] | 77 [72.0–84.0] |
| Males | 23 (52.3%) | 23 (60.1%) | |
| NESB | 5 (11.4%) | 18 (47.4%) | |
| Aged care resident | 4 (9.1%) | 7 (18.4%) | |
| Lives alone | 3 (6.8%) | 10 (26.3%) | |
| Premorbid health status | CCMI ≥ 7 | 14 (31.8%) | 15 (39.5%) |
| Anxiety/depression | 7 (15.9%) | 7 (18.4%) | |
| Chronic pulmonary disease | 26 (59.1%) | 18 (47.4%) | |
| CCF | 9 (20.5%) | 9 (23.7%) | |
| Diabetes | 16 (36.4%) | 16 (42.1%) | |
| Dementia | 1 (2.2%) | 7 (18.4%) | |
| Malnutrition (MST score ≥ 2) | 11 (25.0%) | 15 (39.4%) | |
| Walks without assistance† | 43 (97.7%) | 30 (78.9%) | |
| Disease severity and complications | CURB-65‡ ≥ 3 | 19 (43.2%) | 19 (50.0%) |
| ICU admission | 0 (0%) | 4 (10.5%) | |
| Acute cardiac event | 5 (11.4%) | 8 (21.1%) | |
| Exacerbation CCF | 7 (15.9%) | 5 (13.2%) | |
| Acute confusion | 1 (2.2%) | 10 (26.3%) | |
| Recovery | LOS (days) | 4 [3–5] | 4 [3–6] |
| 30-day readmission | 3 (6.8%) | 6 (15.8%) | |
| In hospital mortality | 0 (0%) | 1 (2.6%) | |
| Death within 30 days | 1 (2.3%) | 3 (7.9%) | |
Abbreviations: CAP community-acquired pneumonia, CCF congestive cardiac failure, CCMI Charlson Comorbidity Index, LOS length of hospital stay, MST score Malnutrition Screening Tool, NESB non-English speaking background (patient may or may not also be proficient in English)
*All data presented are median (interquartile range) or count (percentage)
†Walks without assistance: may use a gait aid but does not require the assistance of another person
‡CURB-65 score comprised of confusion, urea > 7 mmol/L, respiratory rate ≥ 30 per minute, blood pressure < 90 mmHg systolic, ≤ 60 mmHg diastolic, and age ≥ 65 years
Patient-reported outcome measure completion time and missing data by instrument and mode of collection
| EQ-5D | LLFDI | CAP-Sym 18 | |||
|---|---|---|---|---|---|
| Completion time (minutes) (median, [IQ range]) | Admission face-to-face ( | 3 [2–5] | 10 [6–11] | 4 [2.5–5] | |
| 30-day phone ( | 3 [2–5] | 10 [7–13] | 3 [2–5] | ||
| Missing data ( | Instrument level | Face-to-face | 0/87 (0%) | 0/44 (0%) | 0/87 (0%) |
| Phone | 20/78 (25.6%) | 10/44 (22.7%) | 20/78 (25.6%) | ||
| 12/20 (60.0%) | 7/10 (70.0%) | 14/20 (70.0%) | |||
| Item level†: No. of items with > 5% missing values | Face-to-face | 0/6 (0%) | 0/32 (0%) | 0/18 (0%) | |
| Phone | 0/6 (0%) | 2/32 (6.25%) | 0/18 (0%) | ||
| 0/6 (0%) | 0/32 (0%) | 0/18 (0%) | |||
Abbreviations: CAP-Sym 18 CAP-Symptom Questionnaire (18-item version), EQ-5D EuroQol Questionnaire, IQ interquartile, LLFDI Late Life Function and Disability Instrument
*For instrument level data, the denominator represents the total number of occasions the instrument was attempted via that mode. Numbers differ between instruments because the LLFDI was only completed on admission and at 30 days
†For item level data, the denominator represents the number of items in that instrument
Difference in patient-reported outcome measure scores at admission between older and younger participants
| Instrument | Age groups | |
|---|---|---|
| 18–74 years | ≥ 75 years | |
| CAP-Sym 18 score | 34.2 (18.6) | 19.0 (11.3) |
| EQ-5D VAS score | 42.3 (18.8) | 47.6 (21.3) |
| EQ-5D-5L index | 0.54 [0.28–0.84] | 0.68 [0.35–0.88] |
Abbreviations: CAP-Sym 18 CAP-Sym Questionnaire 18-item score, CI confidence interval, EQ-5D VAS EuroQol Quality of Life Questionnaire visual analog score, EQ-5D-5L index score EuroQol 5-dimension 5-level Questionnaire, IQR interquartile range, PROMs patient-reported outcome measure
*Age 18–74 years is the reference group
Fig. 2Change in CAP-Sym 18 and EQ-5D visual analog scores over time according to age group. Instrument scoring (y-axis): CAP-Sym18 score: CAP-Symptom Questionnaire score, consists of 18-items rated 0–5 where 0 has not experienced symptom and 5 extremely bothered by that symptom, total possible score between 0 and 90; EQ-5D VAS score: EQ-5D-5L visual analog scale score, rated as 0–100 where 0 is the worst health imaginable and 100 the best health imaginable. Time points (x-axis): ADM admission assessment conducted on first day of hospitalization, DC discharge assessment conducted on day of discharge, 30: 30-day assessment conducted at 30-days post discharge, 90: 90-day assessment conducted at 90 days post discharge